Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin B Begg

Showing results (131-140 of 184) with videos related to

Pageof 19
Sort By:
JAMA|January 10, 2008
Variation of breast cancer risk among BRCA1/2 carriersColin B Begg, Robert W Haile, Ake Borg, et al.
Journal of the National Cancer Institute|October 20, 2005
Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sampleColin B Begg, Irene Orlow, Amanda J Hummer, et al.
Cancer Causes & Control : CCC|February 5, 2010
Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE studyJenny N Poynter, Bryan Langholz, Joan Largent, et al.
Journal of the National Cancer Institute|April 27, 2012
Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriersBhramar Mukherjee, John Oliver Delancey, Leon Raskin, et al.
Plos One|March 20, 2015
Inherited variation at MC1R and histological characteristics of primary melanomaNicholas J Taylor, Klaus J Busam, Lynn From, et al.
International Journal of Cancer|September 19, 2017
Contralateral breast cancers: Independent cancers or metastases?Colin B Begg, Irina Ostrovnaya, Felipe C Geyer, et al.
Breast Cancer Research and Treatment|February 6, 2010
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancerKerryn W Reding, Jonine L Bernstein, Bryan M Langholz, et al.
Human Mutation|January 28, 2010
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE studyAke Borg, Robert W Haile, Kathleen E Malone, et al.
JNCI Cancer Spectrum|July 26, 2023
Association of functional, inherited vitamin D-binding protein variants with melanoma-specific deathDavid Corley Gibbs, Nancy E Thomas, Peter A Kanetsky, et al.
Carcinogenesis|November 2, 2015
Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based studyIrene Orlow, Anne S Reiner, Nancy E Thomas, et al.
Pageof 19

Showing results (131-140 of 184) with videos related to

Sort By:
Pageof 19
JAMA|January 10, 2008
Variation of breast cancer risk among BRCA1/2 carriersColin B Begg, Robert W Haile, Ake Borg, et al.
Journal of the National Cancer Institute|October 20, 2005
Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sampleColin B Begg, Irene Orlow, Amanda J Hummer, et al.
Cancer Causes & Control : CCC|February 5, 2010
Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE studyJenny N Poynter, Bryan Langholz, Joan Largent, et al.
Journal of the National Cancer Institute|April 27, 2012
Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriersBhramar Mukherjee, John Oliver Delancey, Leon Raskin, et al.
Plos One|March 20, 2015
Inherited variation at MC1R and histological characteristics of primary melanomaNicholas J Taylor, Klaus J Busam, Lynn From, et al.
International Journal of Cancer|September 19, 2017
Contralateral breast cancers: Independent cancers or metastases?Colin B Begg, Irina Ostrovnaya, Felipe C Geyer, et al.
Breast Cancer Research and Treatment|February 6, 2010
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancerKerryn W Reding, Jonine L Bernstein, Bryan M Langholz, et al.
Human Mutation|January 28, 2010
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE studyAke Borg, Robert W Haile, Kathleen E Malone, et al.
JNCI Cancer Spectrum|July 26, 2023
Association of functional, inherited vitamin D-binding protein variants with melanoma-specific deathDavid Corley Gibbs, Nancy E Thomas, Peter A Kanetsky, et al.
Carcinogenesis|November 2, 2015
Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based studyIrene Orlow, Anne S Reiner, Nancy E Thomas, et al.
Pageof 19